Skip to main content

Table 1 Demographic data in 1367 colorectal cancer patients

From: Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment

Variable Case No. Percentage (%)
Age   
   <65 years/≥65 years 624/743 45.6%/54.4%
Gender   
   Male/Female 757/610 55.4%/44.6%
Tumor size   
   ≥5 cm/<5 cm 539/774 39.4%/60.6%
Tumor location   
   Colon/Rectum 920/447 67.3%/32.7%
Histological type   
   Well/Moderately/Poorly 183/1066/118 13.4%/77.9%/8.7%
UICCa Stage   
   I/II/III/IV 230/506/391/240 16.8%/37.1%/28.6%/17.5%
Tumor invasion   
   T1/T2/T3/T4 70/229/989/80 5.1%/16.7%/72.4%/5.8%
Node metastases   
   N0/N1/N2 832/343/192 60.8%/25.2%/14.0%
Serum Albumin level   
   <3.5 gm/dl/≥3.5 gm/dl 392/975 28.7%/71.3%
Serum CEAblevel   
   ≥5 ng/ml/<5 ng/ml 634/724 46.4%/53.6%
  1. aInternational Union Against Cancer
  2. bCarcinoembrynic antigen